Galderma launches transformative skincare segment with Cetaphil’s new Skin Activator Hydrating & Firming Line, in partnership with actor and filmmaker Mariska Hargitay Press release
EADV 2025: Galderma reinforces leadership in dermatology with latest advances in sensitive skin and itch Press release
Galderma launches Alastin® in China, supporting the skin’s natural regenerative abilities in a rapidly expanding market Press release
Galderma introduces Cetaphil Nourishing Oil to Foam Cleanser, a breakthrough in hydrating cleansing for sensitive skin Press release
Galderma delivers record first half 2025 net sales of 2.448 billion USD and 12.2% year-on-year growth at constant currency, raises full-year top-line guidance Press release
Galderma unveils final nine-month data showing lasting efficacy and patient satisfaction with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight loss Press release
Galderma initiates two new clinical trials investigating nemolizumab in patients with Systemic Sclerosis and Chronic Pruritus of Unknown Origin Press release
Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership Press release
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years Press release
